Records containing: Muscular Dystrophy, Facioscapulohumeral
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-24A Randomized, Double-blind, Placebo-controlled, Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Exploratory Efficacy of AOC 1020 Administered Intravenously to Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)
-
CLINICAL_TRIALS study record update · 2026-02-25Clenbuterol to Target DUX4 in FSHD (Target FSHD): Open Label Safety and Tolerability Study of 3 Doses of Clenbuterol
-
CLINICAL_TRIALS study record update · 2026-02-25Motor Outcomes to Validate Evaluations in Pediatric FSHD (MOVE Peds)
-
CLINICAL_TRIALS study record update · 2026-02-20BetterLife FSHD: A Patient-driven Health and Research Platform
-
CLINICAL_TRIALS study record update · 2025-01-13Ultrasound and Magnetic Resonance Imaging for Assessing Muscle Contractile Performance in FSHD - An Exploratory Study
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-12-20A Phase 2 Open-label Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of AOC 1020 Administered Intravenously to Participants with Facioscapulohumeral Muscular Dystrophy (FSHD)
-
CLINICAL_TRIALS study record update · 2024-07-24Disease Burden and Living Situation of Patients With Facioscapulohumeral Muscular Dystrophy
-
CLINICAL_TRIALS study record update · 2023-11-14Clinical, Genetic and Epigenetic Characterization of Patients With FSHD Type 1 and FSHD Type 2
-
CLINICAL_TRIALS study record update · 2023-11-14Neurological and Psychiatric Comorbidities Patients With FSHD 1 and 2
-
CLINICAL_TRIALS study record update · 2022-03-09An Exploratory, Non-interventional Study to Biotype Patients With Facioscapulohumeral Muscular Dystrophy (FSHD) and Controls Using Digital Technologies
-
CLINICAL_TRIALS study record update · 2020-12-16Evaluation of a Method to Support Unstable Shoulders by Means of a Textile Scapula Orthosis
-
CLINICAL_TRIALS study record update · 2015-12-09Prospective Study for 24-months of Physical Training Introduced in Lifestyle of Patients With Facioscapulohumeral Dystrophy : Tolerance, Sustainability and Efficiency of Unsupervised Training Program.
-
CLINICAL_TRIALS study record update · 2015-04-01Exercise and Myopathies. Physical Training Introduction in Lifestyle of Facioscapulohumeral Dystrophy Patients: Functional, Tissue and Quality of Life Benefits.
-
CLINICAL_TRIALS study record update · 2015-03-25ClinicalTrials.gov study NCT00004685